Welcome to Westonci.ca, where finding answers to your questions is made simple by our community of experts. Get quick and reliable solutions to your questions from knowledgeable professionals on our comprehensive Q&A platform. Our platform offers a seamless experience for finding reliable answers from a network of knowledgeable professionals.
Sagot :
The nurse will provide a platelet report to the healthcare provider for the client diagnosed with Hodgkin's disease who received cyclophosphamide.
The primary use of the potent medicine Cyclophosphamide is in cancer treatment. It belongs to the class of cytotoxic drugs called alkylating agents that stop the spread and proliferation of malignant cells.
Some skin disorders, especially those that are autoimmune or connected to an immunological sickness, have been shown to respond well to cyclophosphamide treatment.
A member of the group of medications known as alkylating agents is cyclophosphamide. Cyclophosphamide reduces or stops the growth of cancer cells in your body when used as a cancer treatment. Cyclophosphamide lowers your immune system when used to treat nephrotic syndrome.
Treatment for malignancies of the ovaries, breast, blood, lymphatic, and nervous systems with cyclophosphamide (mainly in children). Additionally, cyclophosphamide is used to treat mycosis fungoides, Hodgkin's disease multiple myeloma, and retinoblastoma, a bone marrow cancer that mostly affects children (tumors on the skin).
To learn more about cyclophosphamide please click on the given link: https://brainly.com/question/28482500
#SPJ4
We hope you found what you were looking for. Feel free to revisit us for more answers and updated information. Thank you for visiting. Our goal is to provide the most accurate answers for all your informational needs. Come back soon. We're dedicated to helping you find the answers you need at Westonci.ca. Don't hesitate to return for more.
